Announcements Trials
Browse Landscape

Phase

Phase 2 251Phase 3 36Phase 1 30Phase 1/2 27Phase NA 16Phase 2/3 12Phase 4 4Phase EARLY_PHASE1 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × sintilimab × Clear all
NCT06347198 2024-04-04

Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Zhejiang Cancer Hospital

Phase EARLY_PHASE1 Unknown
20 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡